Gaithersburg, United States
Viela Bio was founded in 2018 and quickly emerged in the biotechnology industry. However, the company was acquired by Horizon Therapeutics on March 15, 2021. The acquisition signaled a strategic move by Horizon to expand its portfolio with Viela's innovative therapeutic solutions.
As an independent entity, Viela Bio focused on developing groundbreaking treatments targeting autoimmune and severe inflammatory diseases. Although the company's direct operations ceased post-acquisition, its legacy lies in the pivotal advancements it brought to its specialized field.
The lack of a current headquarters and direct investors due to the acquisition does not detract from the significance of its short-lived independent journey in the biotech sector. Venture partners should note that future prospects and developments would now be under the Horizon Therapeutics umbrella.
